Form 4: Phillip Frost, OPKO Health CEO, Acquires 150,000 Shares

OPKO Health's CEO, Phillip Frost, purchased 150,000 shares of common stock at an average price of $1.6959 on March 28, 2025.

Summary

• Phillip Frost, CEO and Chairman of OPKO Health, Inc., acquired 150,000 shares of common stock on March 28, 2025.
• The shares were purchased at a weighted average price of $1.6959, with individual prices ranging from $1.685 to $1.70.
• Following the transaction, Dr. Frost directly owns 3,568,951 shares.
• Dr. Frost also has indirect ownership through Frost Gamma Investments Trust (213,651,448 shares) and Frost Nevada Investments Trust (30,127,177 shares).
• Dr. Frost disclaims beneficial ownership of the indirectly held securities except to the extent of any pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is generally a good sign, but it's a single transaction and doesn't provide a comprehensive view of the company's health.

Positives

• The CEO's purchase of shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive signal, suggesting that a company's management believes the stock is undervalued. However, it's important to consider the overall context and not rely solely on insider trading activity when making investment decisions.

Stakeholder Impact

• The stock purchase could positively influence shareholder sentiment.

Key Dates

Keywords

OPKO Health, Phillip Frost, insider trading, stock purchase, common stock, beneficial ownership, Form 4